4//SEC Filing
Lewis Karen 4
Accession 0001127602-25-001200
CIK 0001492422other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:20 PM ET
Size
4.7 KB
Accession
0001127602-25-001200
Insider Transaction Report
Form 4
Lewis Karen
Chief People Officer
Transactions
- Sale
Common Stock
2025-01-13$28.70/sh−1,599$45,895→ 45,099 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.
- [F2]This includes 116 shares from April 30, 2024 ESPP purchase and 195 shares from the October 31, 2024 ESPP purchase.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001814304
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:20 PM ET
- Size
- 4.7 KB